R&D Novel study designs for rare diseases Developing treatments for rare diseases poses many unique challenges that cannot be addressed by traditional study designs.
R&D Medicine’s blind spot: How clinical trials are failing women From insulin to immunotherapies, clinical trials have powered some of the most important medical breakthroughs of our time.
R&D Transforming drug development with statistical methodologies The product development lifecycle is long and challenging.
Oncology Triumphing in trials There are certain firsts and lasts that we all remember: your first teacher, your first car, your first kiss.
Patients The power of patient insights in shaping successful drug dev... The pharmaceutical industry is undergoing a major transformation, placing patients at the forefront of drug development like never before.
R&D Putting a critical eye on early clinical trial design decisi... Drug development industry stakeholders recognise there is no one-size-fits-all approach to the long-standing challenge of patient recruitment and engagement.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
